AIDX
20/20 Biolabs, Inc. Common Stock
NASDAQ · Healthcare · Medical - Devices · US
$0.59
−3.27%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.85x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.39x
- Price / sales
- 3.70x
- Price / cash flow
- -2.71x
Enterprise value
- Enterprise value
- $5.1M
- EV / sales
- 2.51x
- EV / EBITDA
- -1.07x
- EV / EBIT
- -1.16x
- Market cap
- $7.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026